{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:00:29Z","timestamp":1791000029664,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2008.11.079","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T10:34:25Z","timestamp":1228905265000},"page":"1637-1644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax\u00ae in healthy vaccinia-naive adults"],"prefix":"10.1016","volume":"27","author":[{"given":"Sharon E.","family":"Frey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances K.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getahun","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Monath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2008.11.079_bib1","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/jvi.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus [Journal Article. Research Support, Non-U.S. Gov\u2019t. Research Support, U.S. Gov\u2019t, P.H.S.]","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.11.079_bib2","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vaccine.2008.11.079_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2008.11.079_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal cell culture-grown vaccinia virus (New York City Board of Health strain) as a second-generation smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat Med"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2008.11.079_bib5","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ijid.2004.09.002","article-title":"ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)\u2014a second-generation smallpox vaccine for biological defense","volume":"8","author":"Monath","year":"2004","journal-title":"Internat J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.079_bib6","unstructured":"Advisory Committee on Immunization Practices Membership List, March 2001. Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2001. MMWR Recommendations and Reports June 22, 2001;50(RR10):1\u20132."},{"issue":"RR07","key":"10.1016\/j.vaccine.2008.11.079_bib7","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR"},{"issue":"8","key":"10.1016\/j.vaccine.2008.11.079_bib8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/374564","article-title":"Stability of undiluted and diluted vaccinia (Dryvax\u00ae) virus vaccine","volume":"187","author":"Newman","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.079_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2007.10.063","article-title":"Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge","volume":"26","author":"Marriott","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.11.079_bib10","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/jvi.67.3.1538-1544.1993","article-title":"Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans","volume":"67","author":"Demkowicz","year":"1993","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.079_bib11","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1086\/423848","article-title":"Induction of human T-cell-mediated immune responses after primary and secondary smallpox vaccination","volume":"190","author":"Kennedy","year":"2004","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2008.11.079_bib12","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.11.079_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00915477","article-title":"Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity","volume":"1","author":"Pross","year":"1981","journal-title":"J Clin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.11.079_bib14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/340517","article-title":"Primary induction of human CD8+ cytotoxic T lymphocytes and interferon \u03b3-producing T cells after smallpox vaccination","volume":"185","author":"Ennis","year":"2002","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.079_bib15","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/jvi.66.4.2274-2280.1992","article-title":"Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones","volume":"66","author":"Littaua","year":"1992","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.11.079_bib16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/444423","article-title":"Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions","volume":"192","author":"Abate","year":"2005","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2008.11.079_bib17","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JCM.41.7.3154-3157.2003","article-title":"Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine","volume":"41","author":"Newman","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.11.079_bib18","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-na\u00efve US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.11.079_bib19","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.079_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/oxfordjournals.aje.a121210","article-title":"Epidemiologic investigation of a smallpox outbreak in a town reported to be \u201c100 per cent vaccinated\u201d","volume":"92","author":"Morris","year":"1970","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:53Z","timestamp":1759400153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08016344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X08016344"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax\u00ae in healthy vaccinia-naive adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}